Literature DB >> 25874949

Correction: CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients.

.   

Abstract

Entities:  

Year:  2015        PMID: 25874949      PMCID: PMC4398565          DOI: 10.1371/journal.pone.0126542

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
During typesetting, errors were introduced into the names of the third, fifth, and eighth authors. The third author’s given name should be María de Luján, and the surname should be Calcagno. The fifth author’s given name should be Hernán, and the surname should be Garcia Rivello. The eighth author’s given name should be Valeria Beatriz, and the surname should be Fernández Vallone. The correct citation is: Martinez LM, Labovsky V, Calcagno ML, Davies KM, Garcia Rivello H, Bianchi MS, et al. (2015) CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients. PLoS ONE 10(3): e0121421. doi:10.1371/journal.pone.0121421 The publisher apologizes for the errors.
  1 in total

1.  CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients.

Authors:  Leandro Marcelo Martinez; Vivian Labovsky; María de Luján Calcagno; Kevin Mauro Davies; Hernán Garcia Rivello; Hernán Garcia Rivello; Maria Silvia Bianchi; Alejandra Wernicke; Valeria Beatriz Fernández Vallone; Valeria Beatriz Fernández Vallone; Norma Alejandra Chasseing
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

  1 in total
  1 in total

Review 1.  CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.

Authors:  Xiangyi Kong; Jian Guan; Wenbin Ma; Yongning Li; Bing Xing; Yi Yang; Yu Wang; Jun Gao; Junji Wei; Yong Yao; Zhiqin Xu; Wanchen Dou; Wei Lian; Changbao Su; Zuyuan Ren; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.